Health Innovation Call for Proposals

Selected projects 2024

Selected Projects 2024, Stage 1

  •

    New drugs that modulate tubulin modifications to enhance Taxol treatment in breast cancer

    Sonia Silva

  •

    A new type of drugs to fight acute myeloid leukaemia

    Marcus Buschbeck

  •

    A new type of immunotherapy based on memory T lymphocytes to combat solid tumours

    Marc Veldhoen

  •

    Towards a new treatment for the most deadly and aggressive paediatric brain tumour

    Luciano Di Croce

  •

    Biomarkers to facilitate ALS diagnosis and a new therapy to treat it

    Manuel Portero

  •

    Light-activated drugs to combat chronic pain

    Amadeu Llebaria

  •

    Validation of a tool to predict the genetic risk of myocardial infarction and sudden death in young people

    Ramon Brugada

  •

    Development of an accurate, non-invasive diagnostic method for bladder cancer

    Raphaël Canadas

  •

    Artificial intelligence to predict the course of multiple sclerosis and enable the early application of personalised treatments

    Pablo Naval Baudín

  •

    Development and validation of a rapid, easy and inexpensive test to detect malaria and dengue fever

    Claudio Parolo

  •

    Validation of a new methodology to identify endometrial cancer patients at risk of relapse

    María J. Macias

  •

    Development of a non-invasive method to detect endometrial cancer from urine simples

    Laura Costas

  •

    Artificial intelligence to identify infective endocarditis patients at risk of embolism

    J. Alberto San Román

  •

    A medical device made of bacterial nanocellulose for regenerating cartilage and treatment of osteoarthritis

    Miguel Gama

  •

    Ultrasound device to stimulate the spinal cord and slow the progression of multiple sclerosis

    Pablo Villoslada

  •

    Identification of a biomarker panel for early diagnosis of hereditary diffuse gastric cancer

    Daniel A. Ferreira

Selected Projects 2024, Stage 2

  •

    NanoERT, a technology that improves enzyme replacement therapies

    Julia Lorenzo

  •

    Towards a novel targeted therapy to treat the most prevalent chronic liver disease worldwide

    Cecilia Rodrigues

  •

    A new, more targeted and safer gene therapy to treat acute lymphoblastic leukaemia

    Ana Rita Fragoso

  •

    Towards an effective and safe treatment for osteoporosis

    Joan Roig

  •

    New family of drugs to treat a deadly liver cancer

    Marcos Malumbres

  •

    A portable device to improve social cognition in people with autistic spectrum disorders

    Miguel Castelo-Branco

  •

    An AI-guided robotic device to treat vascular lesions

    João L. Vilaça

  •

    Famba, a real-time surveillance platform for emerging diseases

    Jose Muñoz

  •

    Pioneering CRISPR-Cas-based method for rapid self-diagnosis testing

    Felipe Cortés

  •

    NeurAntigen, an accurate and rapid diagnostic test for autoimmune encephalitis

    Eugenia Martínez Hernández

  •

    Towards the development of antimicrobial membranes for regenerating skin lesions

    Salvio Suarez

Selected Projects 2024, Stage 3

  •

    First immunotherapy for inflammatory bowel disease

    Josep M. Aran

  •

    New device to obtain visual prescriptions more accurately and quickly

    Víctor Rodríguez